Currax Pharmaceuticals Announces First Patient Screened into the INFORMUS Cardiovascular Outcomes Trial

Currax Pharmaceuticals announces the first patient screened and accepted into the CONTRAVE® INFORMUS Cardiovascular Outcomes Trial (NB-CVOT3).

Creative Biogene Debuts Revolutionary Single Cell CRISPR Library Screening Services

Qlucore Diagnostics for Pediatric leukemia takes a Significant step closer to CE marking

Qlucore, a leader in software development for precision cancer diagnostics, has taken the final major step in the process towards a CE-marked medical device for in-vitro diagnostics by submitting the technical documentation to a Notified Body. The CE marked product, Qlucore Diagnostics, is due to be launched in February 2025.

Lactocore Group leverages milk peptides to combat inflammaging

Body-wide inflammation is linked to many chronic diseases, affecting health and longevity. Recent data indicates that milk protein hydrolysate is a promising source of novel bioactive peptides. These peptides have potential application in correcting inflammaging and age-associated metabolic disorders

Vector Laboratories and Navinci Diagnostics Announce Strategic Collaboration to Develop Novel Spatial Proteomic Tools Enabling Biomarker Discovery

Vector Laboratories and Navinci Diagnostics announced that they have signed an agreement to develop cutting-edge biomarker discovery tools, allowing detection of specific protein glycosylation in tissue samples.

Transformative Impact of AR and VR Technologies in Healthcare Amidst the COVID-19 Pandemic

The COVID-19 pandemic has acted as a catalyst for the integration of AR and VR technologies in the healthcare industry. From training healthcare professionals to addressing staff shortages, educating patients, and facilitating treatment and rehabilitation, these immersive technologies have proven their worth in navigating the complexities of the ongoing global health crisis. As the world continues to grapple with the challenges posed by the pandemic, the role of AR and VR in healthcare is likely to evolve and expand, ushering in a new era of innovation and resilience in the face of health emergencies.

Creative Enzymes Revolutionizes the Field with Advanced Industrial Enzyme Production Service

Creative Enzymes Introduces Pyranose Oxidase from Microorganism for Enhanced Industrial Applicability

Creative Proteomics Amplifies Its Services with High-precision Amino Acid Analysis

Creative Proteomics Offers Advanced Steroids Analysis Service for Medical Industry

Cresset Aims to Optimise Drug Discovery with Latest Drug Design Platform Release

Drug discovery specialists Cresset have just released a new version of their drug discovery platform Flare.

Creative Proteomics Bolsters Its Position in Biomarker Discovery with N-Glycan and O-Glycan Profiling Services

CD BioSciences Releases Analysis of Marine Organisms to Drive Marine Bioresearch Forward

CD BioSciences announced the release of their comprehensive analysis of marine organisms aimed at propelling advancements in marine bioresearch.

Accelerating Drug Discovery: Life Science and IT Leaders Explore the Power of Artificial Intelligence April 15-17 in Boston

Recognizing the critical role of artificial intelligence in accelerating drug discovery, Bio-IT World Conference & Expo is offering expanded content on this pivotal technology at its 23rd annual event.

Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board

Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board

MedPharm, Ltd. Expands Senior Leadership Team with New Senior Director of Sales & Marketing

MedPharm, Ltd. is announcing the addition of Daniel Morland to its Senior Leadership Team as Senior Director of Sales & Marketing. Dan has more than 15 years of experience in the pharmaceutical industry and will be based out of the company's Headquarters in Guildford, UK. He will directly oversee MedPharm's global commercial efforts.

CD Formulation Unveils Prominent Pharmaceutical Ingredients and Excipients for Enhanced Medicine Efficacy

Alfa Chemistry Announces Ability to Supply Recombinant Human Collagens

Alfa Chemistry Provides Customized Synthesis Services for Biotinylation Reagents

Amerigo Scientific Released A Well-Selection ELISA Kits Featured with Simplicity and Consistency

Amerigo Scientific is pleased to announce the availability of their well-selection and high-quality optimized ELISA kits designed to accurately measure target-specific proteins with simplicity, reliability, and consistency.